According to the new research report published by Precedence Research, titled “U.S. Digital Therapeutics Market (By Application: Diabetes, Obesity, Central Nervous System Diseases, Cardiovascular Disease, Respiratory Disease, Smoking Cessation, Gastrointestinal Disorder, Others; By Product: Software, Device; By End Use: Patients, Providers, Payers, Employers, Others) – Industry Analysis, Size, Share, Growth, Trends, and Forecast 2022-2030 (By Product: Traditional, Advanced; By Application: Pottery, Tiles, Abrasives, Sanitary wave, Bricks & pipes, Others; By End User: Medical, Industrial, Building & Construction, Others) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022-2030”, the U.S. digital therapeutics market size is expected to be worth around US$ 12.09 billion by 2030 and is poised to record a yearly growth rate of 24.85% from 2022 to 2030. The study investigates several elements and their consequences on the growth of the all-wheel drive market.
This report focuses on U.S. digital therapeutics market volume and value at the global level, regional level and company level. From a global perspective, this report represents the overall U.S. digital therapeutics market size by analysing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, the Middle East & Africa, Latin America, etc.
The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Download a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2410
The study also provides important advancements in organic and inorganic growth strategies in the worldwide U.S. digital therapeutics market. A lot of corporations are prioritizing new launches, product approvals, and other business expansion techniques. In addition, the report offers profiles of U.S. digital therapeutics market firms and market strategies. Furthermore, the research focuses on top industry participants, providing information such as company profiles, components and services offered, recent financial data, and key developments.
U.S. Digital Therapeutics Market Report Scope
| Report Coverage | Details |
| Market Size in 2022 | USD 2.05 Billion |
| Market Size by 2030 | USD 12.09 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 24.85% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
Also read: Enterprise Artificial Intelligence Market Size to Worth US$ 102.9 Billion by 2030
Market Key Players
Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the U.S. digital therapeutics market.
Some of the prominent players in the U.S. digital therapeutics market include
- Omada Health Inc.
- 2Morrow Inc.
- Teladoc Health, Inc
- Pear Therapeutics (U.S), Inc.
- Fitbit Health Solutions
- Welldoc, Inc
- Click Therapeutics
- Noom, Inc.
- Akili, Inc.
- Better Therapeutics, Inc
U.S. Digital Therapeutics Market Segmentations
By Application
- Diabetes
- Obesity
- Central Nervous System Diseases
- Cardiovascular Disease (CVD)
- Respiratory Disease
- Smoking Cessation
- Gastrointestinal Disorder (GID)
- Others
By Product
- Software
- Device
By End Use
- Patients
- Providers
- Payers
- Employers
- Others
Report Objectives
- To define, segment, and project the global market size for U.S. digital therapeutics market
- To understand the structure of the market by identifying its various sub-segments
- To provide detailed information about the key factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
- To analyse the micro-markets, with respect to individual growth trends, future prospects, and their contributions to the total market
- To project the size of the market and its submarkets, in terms of value, with respect to global. (along with their respective key countries)
- To profile key players and comprehensively analyse their core competencies
- To understand the competitive landscape and identify major growth strategies adopted by players across the globe.
- To analyse the competitive developments such as expansions & investments, new product launches, mergers & acquisitions, joint ventures, and agreements
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on U.S. Digital Therapeutics Market
5.1. COVID-19 Landscape: U.S. Digital Therapeutics Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global U.S. Digital Therapeutics Market, By Application
8.1. U.S. Digital Therapeutics Market, by Application, 2022-2030
8.1.1 Diabetes
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Obesity
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Central Nervous System Diseases
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Cardiovascular Disease (CVD)
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Respiratory Disease
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Smoking Cessation
8.1.6.1. Market Revenue and Forecast (2017-2030)
8.1.7. Gastrointestinal Disorder (GID)
8.1.7.1. Market Revenue and Forecast (2017-2030)
8.1.8. Others
8.1.8.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global U.S. Digital Therapeutics Market, By Product
9.1. U.S. Digital Therapeutics Market, by Product, 2022-2030
9.1.1. Software
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Device
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global U.S. Digital Therapeutics Market, By End Use
10.1. U.S. Digital Therapeutics Market, by End Use, 2022-2030
10.1.1. Patients
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Providers
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Payers
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Employers
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global U.S. Digital Therapeutics Market, Regional Estimates and Trend Forecast
11.1. U.S.
11.1.1. Market Revenue and Forecast, by Application (2017-2030)
11.1.2. Market Revenue and Forecast, by Product (2017-2030)
11.1.3. Market Revenue and Forecast, by End Use (2017-2030)
Chapter 12. Company Profiles
12.1. Omada Health Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. 2Morrow Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Teladoc Health, Inc
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Pear Therapeutics (U.S), Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Fitbit Health Solutions
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Welldoc, Inc
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Click Therapeutics
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Noom, Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Akili, Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Better Therapeutics, Inc
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Why should you invest in this report?
If you are aiming to enter the global U.S. digital therapeutics market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for U.S. digital therapeutics are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
